Actively Recruiting
Optimization of Complex Percutaneous Coronary Intervention With Liberal Use of Intracoronary Imaging Versus Contemporary Practice
Led by Cathreine BV · Updated on 2026-03-27
11092
Participants Needed
1
Research Sites
108 weeks
Total Duration
On this page
Sponsors
C
Cathreine BV
Lead Sponsor
P
Philips Healthcare
Collaborating Sponsor
AI-Summary
What this Trial Is About
Coronary artery disease remains a leading cause of mortality worldwide and is commonly treated with percutaneous coronary intervention (PCI). Typically, PCI is guided by invasive coronary angiography (ICA). However, ICA has inherent limitations in accurately assessing vessel dimensions, calcium burden, circumferential tissue and whether a stent has achieved full expansion. Therefore ICA alone is insufficient for guiding stent optimization, especially in complex lesions which are most vulnerable to long-term stent failure. To overcome the limitations of ICA, intracoronary imaging can be used to guide and optimize PCI. The advantages of intracoronary imaging include obtaining larger lumen areas, better stent expansion and strut apposition, full lesion stent coverage and identifying stent complications. Multiple randomized studies have shown that these advantages translate into a reduction in major adverse cardiovascular events (MACE) in complex PCI. Consequently, the recommendation for intracoronary imaging has been upgraded in the most recent guidelines. Despite robust evidence supporting its benefits, intracoronary imaging remains relatively underused in real-world practice and in the Netherlands it is only used in 7% of complex PCI procedures. This underutilization may be attributed to several factors, including operator and hospital-dependent issues such as lack of experience, reluctance to spend additional time on intracoronary imaging and concerns about its cost-effectiveness. Therefore, initiating an implementation project to incorporate intracoronary imaging into routine use in the catheterization lab during complex PCI would be highly valuable. Such a project could make imaging-guided PCI the standard of care in complex PCI. Additionally, it could evaluate the cost-effectiveness of routine intracoronary imaging during complex PCI. For this reason we designed the OPTIMIZE-PCI II, a national registry-based quality improvement project. This project is aimed at implementing a liberal intracoronary imaging-guided strategy for complex PCI across multiple centres in the Netherlands, with data extraction from the Netherlands Heart Registration (NHR) database. The objective of the OPTIMIZE-PCI II is to establish a routine use of intracoronary imaging in complex PCI, to determine if this approach reduces adverse cardiac events in real-world practice, and evaluate its cost-effectiveness.
CONDITIONS
Official Title
Optimization of Complex Percutaneous Coronary Intervention With Liberal Use of Intracoronary Imaging Versus Contemporary Practice
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years and older included in the Netherlands Heart Registration (NHR) after receiving PCI for complex coronary lesions
- Complex lesions meeting one or more criteria:
- Left main stenosis 50% or FFR 0.80 or iFR 0.89 in the left main artery
- Severely calcified lesions requiring calcium modification therapy
- Chronic total occlusion with TIMI flow 0, absence of contrast stasis at proximal capillaries, presence of collateral vessels, and at least 3 months occlusion
- Ostial lesion within 5 mm of a major coronary vessel origin
- Long lesion with total stent length 38 mm
- True bifurcation involving a side branch 2.5 mm (Medina 1,1,1; 1,0,1; 0,1,1)
- In-stent restenosis with 50% luminal diameter reduction within or near stent edges
You will not qualify if you...
- Patients with non-complex PCI
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Catharina hospital Eindhoven
Eindhoven, North Brabant, Netherlands, 5623EJ
Actively Recruiting
Research Team
K
Koen Teeuwen, MD PhD
CONTACT
K
Konrad AJ van Beek, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here